HTB
-
Featured
HTB 2024: latest news online
3 January 2024. Related: Editorial.
-
HCV coinfection approaches zero in Spain: but cirrhosis and reinfection among gay men are still significant even with high rates of cure
26 November 2024. Related: Conference reports, Hepatitis coinfection, HIV 17 Glasgow 2024.
-
Dolutegravir/lamivudine vs triple ART have similar efficacy in advanced HIV infection with CD4 <200 and viral load >100,000
21 November 2024. Related: Conference reports, Antiretrovirals, HIV 17 Glasgow 2024.
-
EACS guidelines: New format and contents includes chemsex
21 November 2024. Related: Conference reports, Guidelines, HIV 17 Glasgow 2024.
-
GLASGOW 2024: Future PrEP and new results from PURPOSE 1 and 2 – does HIV exposure explain incident cases?
21 November 2024. Related: Conference reports, HIV prevention and transmission, HIV 17 Glasgow 2024.
-
Glasgow 2024: Double dose start for oral PrEP in new EACS guidelines – rapid protection in two hours
14 November 2024. Related: Conference reports, Guidelines, HIV prevention and transmission, HIV 17 Glasgow 2024.
-
Liverpool University Drug Interaction website recognised for global impact on research and care
14 November 2024. Related: Conference reports, PK and drug interactions, Treatment advocacy, HIV 17 Glasgow 2024.
-
Glasgow 2024: Once-weekly oral ART with islatravir plus lenacapavir sustains results to week 48
14 November 2024. Related: Conference reports, Antiretrovirals, HIV 17 Glasgow 2024.
-
Once-weekly oral ART: islatravir plus lenacapavir 48 week results in phase 2 switch study
13 November 2024. Related: Other news.
-
Glasgow HIV Congress 2024: Introduction and links
10 November 2024. Related: Conference reports, Conference index, HIV 17 Glasgow 2024.
-
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024. Related: Early access, Book and film reviews.
-
WHO toolkit to strengthen engagement of health workers in emergency responses
5 November 2024. Related: On the web.
-
HTB news: i-Base changes during 2024
1 November 2024. Related: Editorial, Special reports.
-
Bipolar disorder in people living with HIV
1 November 2024. Related: Early access, Coinfections and complications.
-
Mpox breakthrough cases after two doses of the MVA-BN vaccine
1 November 2024. Related: Early access, mpox (monkeypox).
-
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
1 November 2024. Related: Early access, Treatment access, Paediatric care, Drug resistance.
-
Future meetings and webinars 2024/2025
1 November 2024. Related: Future meetings.
-
Confirmed mpox clade 1b case in Germany: risk remains low for EU/EEA
23 October 2024. Related: mpox (monkeypox).
-
Helsinki Declaration: 2024 edition upholds ethical access to treatment
23 October 2024. Related: Treatment access, HIV prevention and transmission.
-
Lack of tecovirimat activity against mpox clade 1
21 October 2024. Related: mpox (monkeypox), Coinfections and complications.
-
Efficacy of MVA-BN vaccine: systematic review
21 October 2024. Related: mpox (monkeypox).
-
Kidney transplants from HIV positive donors to HIV recipients
17 October 2024. Related: Coinfections and complications, Cancer and HIV.
-
US NIAID updates HIV guide to person-centred language
17 October 2024. Related: Treatment advocacy, Book and film reviews, On the web.
-
Long COVID essentials: link to online resources
15 October 2024. Related: On the web, COVID-19.
-
Urgency of planning broad vaccine-like access to lenacapavir PrEP globally
13 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission, R4P 2024 Lima.
-
Impact on CD4 counts of once-monthly islatravir in PrEP studies: early macaque results with MK-8527 follow-on compound
9 October 2024. Related: Conference reports, Antiretrovirals, HIV prevention and transmission, R4P 2024 Lima.
-
Lenacapavir PrEP in cisgender gay men, trans and gender-diverse people: results of the PURPOSE 2 study
9 October 2024. Related: Conference reports, HIV prevention and transmission, R4P 2024 Lima.
-
HIVR4P 2024: Context of PrEP in Latin America
7 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission, R4P 2024 Lima.
-
HIVR4P 2024: Introduction
7 October 2024. Related: Conference reports, Treatment access, HIV prevention and transmission, Conference index, R4P 2024 Lima.
-
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024. Related: Special reports.
-
Mpox outbreak in Australia: half of cases had previously received a vaccine
3 October 2024. Related: mpox (monkeypox).
-
Gilead announces plans to support generic lenacapavir for low-income countries
2 October 2024. Related: Treatment access.
-
WHO situation report on mpox
2 October 2024. Related: mpox (monkeypox).
-
Major update of UK PrEP guidelines online for public consultation
1 October 2024. Related: Special reports, Guidelines, HIV prevention and transmission.
-
NICE defers decision on CAB-LA as PrEP needing more information
27 September 2024. Related: Treatment access, HIV prevention and transmission.
-
Second lenacapavir PrEP study protected 99.9% of people in the PURPOSE 2 trial: ACT UP London challenge pricing
26 September 2024. Related: HIV prevention and transmission.
-
UNAIDS reports debt crisis obstructs HIV response
19 September 2024. Related: Treatment access, Other news.
-
i-Base library archived at the Bishopsgate Institute and Wellcome Collection
17 September 2024. Related: Treatment advocacy, Other news.
-
New HIV drug interactions, statin resource and free hybrid workshop
17 September 2024. Related: PK and drug interactions.
-
UK orders 150,000 doses of MVA-BN mpox vaccine
16 September 2024. Related: mpox (monkeypox).
-
ART, weight changes and obesity: results from CASCADE cohort
16 September 2024. Related: Side effects, Lipodystrophy and metabolic complications.
-
Activist pin-up calendar from ACT UP London
11 September 2024. Related: Treatment advocacy, Book and film reviews, Other news.
-
AIDS 2024: Including people living with HIV in non-HIV research
11 September 2024. Related: Conference reports, Treatment access, Cancer and HIV, Treatment advocacy.
-
New guidelines for HIV-related lymphoma
3 September 2024. Related: Guidelines.
-
Responses to mpox clade 1b emergency: webinar details
1 September 2024. Related: mpox (monkeypox).
-
IAS 2024: Open letter to IAS over online access
1 September 2024. Related: Editorial, Conference reports, World AIDS 25 Munich 2024.
-
WHO declares new mpox emergency (clade 1b): tecovirimat not effective in DRC study
16 August 2024. Related: mpox (monkeypox).
-
AIDS 2024: Ten early reports
12 August 2024. Related: Conference reports, Antiretrovirals, World AIDS 25 Munich 2024.
-
BMS to discontinue atazanavir/cobicistat (Evotaz) in September 2024
12 August 2024. Related: Antiretrovirals.
-
Five days on two days off: Biktarvy in pilot FOTO study
12 August 2024. Related: Conference reports, Antiretrovirals, World AIDS 25 Munich 2024.
-
Subcutaneous formulation of long-acting CAB/RPV discontinued
10 August 2024. Related: Conference reports, Antiretrovirals, World AIDS 25 Munich 2024.